Literature DB >> 21431292

Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome.

Thierry Zenone1.   

Abstract

The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431292     DOI: 10.1007/s00296-011-1851-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

3.  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

Authors:  Karin Ekström Smedby; Henrik Hjalgrim; Johan Askling; Ellen T Chang; Henrik Gregersen; Anna Porwit-MacDonald; Christer Sundström; Måns Akerman; Mads Melbye; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

4.  Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.

Authors:  Lesley A Anderson; Shahinaz Gadalla; Lindsay M Morton; Ola Landgren; Ruth Pfeiffer; Joan L Warren; Sonja I Berndt; Winnie Ricker; Ruth Parsons; Eric A Engels
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

Review 5.  The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Authors:  Elias Zintzaras; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Increased risk of lymphoma in sicca syndrome.

Authors:  S S Kassan; T L Thomas; H M Moutsopoulos; R Hoover; R P Kimberly; D R Budman; J Costa; J L Decker; T M Chused
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

7.  Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Marta Perez-DE-Lis; Candido Diaz-Lagares; Albert Bove; Maria-Jose Soto; Iratxe Jimenez; Rafael Belenguer; Antoni Siso; Africa Muxí; Francesca Pons
Journal:  J Rheumatol       Date:  2010-01-15       Impact factor: 4.666

8.  Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort.

Authors:  Wen Zhang; Sheng Feng; Shumin Yan; Yan Zhao; Mengtao Li; Jian Sun; Feng-Chun Zhang; Quancai Cui; Yi Dong
Journal:  Rheumatology (Oxford)       Date:  2009-12-29       Impact factor: 7.580

9.  Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.

Authors:  Evangelia Baimpa; Issa J Dahabreh; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2009-09       Impact factor: 1.889

10.  Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Authors:  Karin Ekström Smedby; Claire M Vajdic; Michael Falster; Eric A Engels; Otoniel Martínez-Maza; Jennifer Turner; Henrik Hjalgrim; Paolo Vineis; Adele Seniori Costantini; Paige M Bracci; Elizabeth A Holly; Eleanor Willett; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Nikolaus Becker; Silvia De Sanjosé; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Andrew E Grulich; Wendy Cozen
Journal:  Blood       Date:  2008-02-08       Impact factor: 22.113

View more
  2 in total

1.  Cutaneous mucosa-associated lymphoid tissue lymphoma complicating Sjögren's syndrome: A case report and review of literature.

Authors:  Ying Liu; Jian Zhu; Yan-Hong Huang; Qian-Ru Zhang; Li-Ling Zhao; Ruo-Han Yu
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

2.  Ultrasound-Guided Biopsy of Suspected Salivary Gland Lymphoma in Sjögren's Syndrome.

Authors:  Alan N Baer; Thomas Grader-Beck; Brendan Antiochos; Julius Birnbaum; Joel M Fradin
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-06       Impact factor: 5.178

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.